Valneva reports further heterologous booster data for its inactivated covid-19 vaccine

Saint- herb lain (france ) , december 30 , 202 2 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today reported further heterologous booster data from an exploratory, small clinical study for its inactivated covid-19 vaccine, vla2001.
VALN Ratings Summary
VALN Quant Ranking